Versant Capital Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
Versant Capital Management's HRMY Position: Q3 2026 in Review
Versant Capital Management held its Harmony Biosciences (HRMY) position steady in Q3 2026 at 364 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2123.
Versant Capital Management first reported a position in HRMY in Q2 2022 and has held it in 18 quarters since. 358 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.
- Versant Capital Management held 364 shares of Harmony Biosciences worth $14.3K as of Q3 2026.
- Versant Capital Management left its Harmony Biosciences share count unchanged in Q3 2026.
- Harmony Biosciences made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2123 holding.
- Versant Capital Management first reported a position in Harmony Biosciences in Q2 2022 and has held it in 18 quarters since.
- 358 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.